Susquehanna International Group, LLP Aprea Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.32 - $15.2 $1,375 - $65,314	-4,297 Reduced 24.33%	13,365 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.71 - $13.6 $31,449 - $602,412	-44,295 Reduced 71.49%	17,662 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.94 $30,635 - $95,859	-49,412 Reduced 44.37%	61,957 $46,000
Q1 2022 May 16, 2022	BUY	$1.59 - $3.16 $72,472 - $144,032	45,580 Added 69.28%	111,369 $208,000
Q4 2021 Feb 14, 2022	SELL	$2.87 - $5.58 $384,189 - $746,961	-133,864 Reduced 67.05%	65,789 $189,000
Q3 2021 Nov 15, 2021	BUY	$3.43 - $5.63 $434,210 - $712,712	126,592 Added 173.27%	199,653 $1.02 Million
Q2 2021 Aug 11, 2021	BUY	$4.05 - $5.5 $295,897 - $401,835	73,061 New	73,061 $357,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,822
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.